Remove 2018 Remove Assay Development Remove Clinical Development Remove Pharmacokinetics
article thumbnail

The essential role of recombinant phage display antibody libraries

Drug Target Review

Overcoming traditional antibody generation limitations with recombinant technologies Antibodies remain essential tools in this ever-changing field for preclinical bioanalysis and drug monitoring through ligand-binding assays (LBAs). 2018 Dec 5;11(1):178–90. Adapted from Harth S et al. (8) 8) under a CC BY-NC-ND 4.0.

article thumbnail

The evolution of assays for immuno-oncology research

Drug Discovery World

The number of new cases recorded between 2016 and 2018 was 375,400, with 167,142 deaths caused by cancer between 2017 and 2019. These models have greatly contributed to the clinical development of several tumour immunotherapies. Great strides have been made in this journey during the last decade.

Research 130